[Retinol-binding protein, haptoglobin and ceruloplasmin--tumor markers in colorectal cancer?].
Retinol-binding protein, haptoglobin and ceruloplasmin were determined in the plasma of patients with colorectal carcinoma. The comparison with a control group shows that retinol-binding is significantly decreased in colorectal carcinoma and that haptoglobin and ceruloplasmin are significantly elevated. The ROC-curves of the three parameters, however, display a sensitivity distinctly lower than that of CEA, so that any use in the clinical treatment of colorectal carcinoma cannot be expected from the determination of these substances.
Putzki
H
H
Klinik und Poliklinik für Allgemeinchirurgie, Medizinischen Hochschule, Hannover.
Reichert
B
B
Hinz
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D002570:Ceruloplasmin / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006242:Haptoglobins / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012372:ROC Curve; D012177:Retinol-Binding Proteins / Q000032:analysis*; D054839:Retinol-Binding Proteins, Plasma
D014408:Biomarkers, Tumor; D006242:Haptoglobins; D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma; D002570:Ceruloplasmin
Retinolbindendes Protein, Haptoglobin und Coeruloplasmin--Tumormarker beim kolorektalen Karzinom?